ArticleBreast cancer research and treatment2024

Measuring cfDNA integrity as a biomarker for predicting neoadjuvant chemotherapy response in breast cancer patients: a pilot study.

Camila Giro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.